SBI BlueChip Fund: Recording Growth At a Steady Pace

In view of this, investors can consider trimming their allocation to smaller caps and shift allocation to Large-cap Funds. Investing in Large-cap Funds can give you the benefit of stability of the portfolio and steady growth of capital over the long term.

SBI BlueChip Fund is one of the well-managed schemes in the Large-cap Funds category that has generated decent risk-adjusted returns for its long-term investors.

Data as on December 29, 2021
(Source: ACE MF)

In the last 1-year, 2-year, and 3-year period, SBI BlueChip Fund's performance has been nearly in line with its benchmark S&P BSE 100 - TRI. However, over a 5-year period the fund has trailed the benchmark by a percentage point. Notably, the fund's performance had slipped between CY 2018 and 2019, which has impacted its returns. Most other prominent large-cap peers too struggled to keep up their performance during this period. Over the longer time period of 7 years, SBI BlueChip Fund has maintained a decent lead over the benchmark and generated an alpha of about a percentage point, and has also outperformed the category average.

SBI BlueChip Fund has encountered reasonable volatility. It has generated decent risk-adjusted returns (as denoted by the Sharpe ratio), which is well in line with its benchmark and the category average and has fared better than many other prominent large-cap peers.

Investment strategy of SBI BlueChip Fund

Being categorised under Large-cap funds, SBI BlueChip Fund has a mandate to invest a minimum 80% of its assets in large-cap stocks. While the fund's portfolio remains biased towards large-caps, it does make opportunistic allocations to mid-caps, which is kept well within the mandated limit. Erstwhile, the fund maintained its own definition of large-caps, but now has to stick to the list provided by AMFI. SEBI has stipulated that the first 100 stocks by market capitalisation will be considered as large-caps.

The fund manager aims to invest in such large-sized companies that have an established business presence, good reputation, healthy brand equity, and are possibly market leaders in their industries. The investment team also aims to keep an eye on consistency in management performance, change in leadership, as well as key management decisions that can affect the outlook of the business.

SBI BlueChip Fund usually holds about 50-60 stocks in its portfolio and follows a buy-and-hold investment strategy, which reflects the strong long-term conviction the fund management has while picking stocks for the portfolio. The funds turnover ratio has ranged between 10%-20% in the last one year, indicating low churn in the portfolio.

As of November 30, 2021, SBI BlueChip Fund held a well-diversified portfolio of as many as 56 stocks. The top-10 stocks accounted for around 47.8% of the portfolio. HDFC Bank topped the list with an allocation of around 8.4%, followed by some other popular large-cap names like ICICI Bank, Infosys, Reliance Industries, L&T, HCL Technologies, HDFC Ltd., and so on. Notably, the top portfolio holdings contain a good mix of stocks belonging to different sectors.

In the last one year, stocks of ICICI Bank, Infosys, L&T, SBI, HCL Technologies, among others have turned out to be the major contributors to its gains. However, its holdings in Hero MotoCorp, Strides Pharma Science, Aurobindo Pharma, Eicher Motors, among others slightly dragged down the fund's performance during the period.

Nearly one-third of SBI BlueChip Fund's portfolio is exposed to Banking and Finance stocks, of which banks account for 21.2% while other finance stocks account for 11%. Infotech, Engineering, Auto, Pharma, Petroleum, Consumption, and Auto Ancillaries are the other top holdings with an allocation in the range of around 4%-11% each. The top 5 sectors in the fund's portfolio together account for around 59% of its assets.

Suitability

SBI BlueChip Fund holds a commendable performance track record over longer time periods. It has done well to curb the downside risk, while the performance on the upside has been in line with that of the benchmark. The fund's strategic minor allocation to mid-caps helps it generate significant growth during mid-cap rallies, leaving many other large-cap funds behind. Though the mid-cap allocation exposes the fund to a higher risk, the fund management made sure that the risk is kept within limits.

Notably, SBI BlueChip Fund is completely benchmark agnostic, and its allocation to certain stocks/sectors may significantly deviate from the benchmark. Thus, the returns of the fund may not always be in line with the benchmark.

SBI BlueChip Fund is suitable for long-term investors looking for stability as well as high growth from a large-cap biased fund over a long-term investment horizon of at least 3 to 5 years.

Warm Regards,
Divya Grover
Research Analyst

PS: If you are looking for quality mutual fund schemes (including Equity-linked Saving Schemes) to add to your investment portfolio, I suggest you subscribe to PersonalFN's premium research service, FundSelect. PersonalFN's FundSelect service provides insightful and practical guidance on which mutual fund schemes to Buy, Hold, and Sell.

Currently, with the subscription to FundSelect, you could also get Free Bonus access to PersonalFN's Debt Fund recommendation service   DebtSelect.

If you are serious about investing in a rewarding mutual fund scheme, subscribe now!

Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.

Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

1. Money Simplified Services Private Limited;

2. PersonalFN Insurance Services India Private Limited;

3. Equitymaster Agora Research Private Limited;

4. Common Sense Living Private Limited;

5. Quantum Advisors Private Limited;

6. Quantum Asset Management Company Private Limited;

7. HelpYourNGO.com India Private Limited;

8. HelpYourNGO Foundation;

9. Natural Streets for Performing Arts Foundation;

10. Primary Real Estate Advisors Private Limited;

11. HYNGO India Private Limited;

12. Suresh Lulla;

13. I V Subramaniam.

1. ‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;

2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company;

3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

1. The Research Analyst has not served as an officer, director or employee of the subject Company.

2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Click here to read PersonalFN's Mutual Fund Rating Methodology

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. & Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021

Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013